Product image of Axira 35 (Cyproterone Acetate, Ethinylestradiol) supplied by GNH India

Axira 35

Active Ingredient:
Cyproterone Acetate, Ethinylestradiol
Origin:
EU

Axira 35 (Cyproterone Acetate, Ethinylestradiol)

Axira 35 is a combined oral contraceptive containing Cyproterone Acetate and Ethinylestradiol. It is used for birth control and may help manage hormonal acne. Learn more about its uses and effects.

Manufacturer / TM Owner

Mibe Pharmaceuticals D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Axira 35 is primarily used for contraception, helping to prevent pregnancy by regulating hormonal levels. Additionally, it may be prescribed to manage symptoms of hormonal acne, offering a dual benefit for those seeking both birth control and skin care solutions. Always consult a healthcare provider to determine if this medication is suitable for your needs.

Side Effects

  • Common effects of Axira 35 may include changes in menstrual cycles, such as lighter or more regular periods. Some users may experience mild side effects like nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

  • Axira 35 should be handled with care, especially by those with a history of blood clots, liver disease, or certain types of cancer. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Always store it in a cool, dry place away from children.

Avoid Interactions

  • Axira 35 may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and antifungal drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, smoking and excessive alcohol consumption may impact the effectiveness and safety of this medication.

Frequently Asked Questions

Axira 35 is used primarily for contraception and may also help manage hormonal acne.

Axira 35 is taken orally, typically once a day, following the instructions provided by your healthcare provider.

Common side effects may include nausea, breast tenderness, headaches, and changes in menstrual cycles.

Axira 35 may help manage hormonal acne, but it is primarily a contraceptive. Consult a healthcare provider for specific acne treatments.

Axira 35 may not be suitable for individuals with certain medical conditions, such as blood clots or liver disease. Always consult a healthcare provider before use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cyproterone Acetate, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT